Christopher C. Caillouet

Array ( [id] => 8630181 [patent_doc_number] => 08362252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Carbostyril compound' [patent_app_type] => utility [patent_app_number] => 12/611921 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 112493 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12611921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6455019 [patent_doc_number] => 20100105681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => '2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/604959 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31671 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105681.pdf [firstpage_image] =>[orig_patent_app_number] => 12604959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321383 [patent_doc_number] => 20100113508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Modulators of Cystic Fibrosis Transmembrane Conductance Regulator' [patent_app_type] => utility [patent_app_number] => 12/605053 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22251 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113508.pdf [firstpage_image] =>[orig_patent_app_number] => 12605053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909677 [patent_doc_number] => 08481741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Preparation methods of 6 substituted amino-3 cyanoquinoline compounds and the intermediates thereof' [patent_app_type] => utility [patent_app_number] => 13/125721 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8214 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321391 [patent_doc_number] => 20100113509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR' [patent_app_type] => utility [patent_app_number] => 12/605250 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18342 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113509.pdf [firstpage_image] =>[orig_patent_app_number] => 12605250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8625205 [patent_doc_number] => 08357700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => '2,3-disubstituted piperidine orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/125191 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12592 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307404 [patent_doc_number] => 20100069435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'METHOD OF SELECTIVELY INTRODUCING AMINO SUBSTITUENT' [patent_app_type] => utility [patent_app_number] => 12/578155 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4616 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069435.pdf [firstpage_image] =>[orig_patent_app_number] => 12578155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321481 [patent_doc_number] => 20100113522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/578498 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62670 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113522.pdf [firstpage_image] =>[orig_patent_app_number] => 12578498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797147 [patent_doc_number] => 08436016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Fused heterocyclic M1 receptor positive allosteric modulators' [patent_app_type] => utility [patent_app_number] => 13/122884 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12557 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9483146 [patent_doc_number] => 08729097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and SIRT1, and methods of treating disorders' [patent_app_type] => utility [patent_app_number] => 13/122876 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 32 [patent_no_of_words] => 26471 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858647 [patent_doc_number] => 08461182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => '7-piperidinoalkyl-3, 4-Dihydroquinolone derivative' [patent_app_type] => utility [patent_app_number] => 13/122281 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22576 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772643 [patent_doc_number] => 08426600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Method for preparing montelukast sodium salts' [patent_app_type] => utility [patent_app_number] => 13/062353 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4481 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778972 [patent_doc_number] => 20120041208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PROCESS FOR MAKING QUINOLONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/120278 [patent_app_country] => US [patent_app_date] => 2009-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11559 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041208.pdf [firstpage_image] =>[orig_patent_app_number] => 13120278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386376 [patent_doc_number] => 08263774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Quinoline-oxazoline compounds and their use in oxidation synthesis' [patent_app_type] => utility [patent_app_number] => 12/553352 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7780 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12553352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363854 [patent_doc_number] => 08252933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => '2-oxo-1,2-dihydro-quinoline modulators of immune function' [patent_app_type] => utility [patent_app_number] => 12/552663 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11279 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12552663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703169 [patent_doc_number] => 08088924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor' [patent_app_type] => utility [patent_app_number] => 12/585057 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 97254 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088924.pdf [firstpage_image] =>[orig_patent_app_number] => 12585057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8470076 [patent_doc_number] => 08299254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Preparation of pyridonecarboxylic acid antibacterials' [patent_app_type] => utility [patent_app_number] => 12/543240 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7622 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12543240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478332 [patent_doc_number] => 20100041653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'COMPOSITION AND METHODS FOR THE DESIGN AND DEVELOPMENT OF METALLO-ENZYME INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/541871 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3148 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041653.pdf [firstpage_image] =>[orig_patent_app_number] => 12541871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270407 [patent_doc_number] => 08211911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Compounds as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/540300 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7813 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12540300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214334 [patent_doc_number] => 20110136863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'N-Heterocyclic M1 Receptor Positive Allosteric Modulators' [patent_app_type] => utility [patent_app_number] => 13/057079 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15546 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136863.pdf [firstpage_image] =>[orig_patent_app_number] => 13057079 [rel_patent_id] =>[rel_patent_doc_number] =>)